NASDAQ
Adaptive Biotechnologies Corporation (ADPT) has a free cash flow growth of -828.19% as of Friday, May 29, 2026. This represents a 4207.91% decrease compared to its 12-month average of 20.16%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.